基本信息
浏览量:83
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
His team is developing new local ocular drug delivery systems including a new intraocular crystalline lipid prodrug delivery platform, a porous silicon based ocular drug delivery system, and transscleral drug delivery system. These drug delivery systems are an effective approach to achieve a sustained therapeutic drug level in the posterior segment of an eye. With these systems, patients can avoid frequent intravitreal injections for treatment of many refractory vitreoretinal diseases such as macular degeneration and diabetic macular edema. He and his colleague have been published extensively in the area of ocular drug delivery, ocular toxicology, ocular pharmacology, as well as clinical management of vitreoretinal diseases.
研究兴趣
论文共 104 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Daniel N Deussen,Anna Heinke, Wyatt Elsner,Carlo Miguel B Galang,Fritz Gerald P Kalaw,Alexandra Warter,Dirk-Uwe Bartsch,Lingyun Cheng,William R Freeman
Scientific reportsno. 1 (2024): 13990-13990
Eyeno. 8 (2024): 1-7
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASESno. 3 (2024): 465-474
Retina (Philadelphia, Pa.)no. 4 (2023): 555-559
Eyeno. 6 (2023): 1-7
Fritz Gerald P. Kalaw,Alexandra Warter,Melina Cavichini,Darren Knight,Alexandria Li, Daniel Deussen,Carlo Galang,Anna Heinke, Veronica Mendoza,Shyamanga Borooah,Sally L. Baxter,Dirk-Uwe Bartsch,
引用0浏览0引用
0
0
Jinlei Ma, Fangyuan Wu, Zhiyong Liu, Yijiong Fang, Xu Chu,Linyan Zheng,Anquan Xue,Kaihui Nan,Jia Qu,Lingyun Cheng
FRONTIERS IN MEDICINE (2022): 888542
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn